Two new local cases of monkeypox were reported for the first time in China recently. Xie Simin, an attending physician at the Department of Infectious Diseases at National Taiwan University Hospital, believed that the two cases were scattered in the north and south and had nothing to do with each other. He judged that an invisible chain of transmission had appeared in the community and called on the government to purchase additional drugs and vaccines.
In this regard, Luo Yijun, deputy director of the CDC, said today that the two cases are young and middle-aged men who live in the south and north respectively, and the epidemic is still under investigation. Since the main route of infection of monkeypox is close contact, family members and other objects are mainly listed.
Luo Yijun said that in response to the emergence of local cases, the risk of local infection has increased. Regarding vaccination, we will hold an expert meeting this evening, and a meeting with non-governmental organizations, hoping to accurately target risk targets.
At present, the total number of people listed remains 25, and there are no new additions. Six of them are high-risk contacts. According to the test results, they are currently asymptomatic, but they still need to be tracked for 21 days. If they have symptoms, they will be tested in accordance with the working rules.
Luo Yijun said that the expert meeting tonight will formulate the vaccination strategy, and it will be mentioned that experts will discuss that the use of 0.1CC by intradermal injection can reach the efficacy of 0.5CC, so that the vaccine can be more effectively applied.
The other is pre-exposure prophylaxis. For vaccination recommendations, it is provided to those who operate and cultivate monkeypox laboratories for prevention. Others, such as vaccination of close contacts following exposure, higher risk of infection due to occupational relationship and exposure relationship will also be discussed.
Do you want to buy more medicines or vaccines? Luo Yijun said that the number of vaccines will definitely increase and he has already contacted the pharmaceutical factory, but it is still necessary to discuss the scope of the vaccination target at an expert meeting and estimate the number of people before there will be a clearer purchase plan.
Wang Bisheng said that the additional purchases of vaccines will be processed first, but the number of additional purchases depends on the number of people who are going to be vaccinated. The most effective way to curb the transmission must be found. A meeting will be held at night and tomorrow will be discussed with civil society groups.
